Clarus Therapeutics Holdings Inc. logo

Clarus Therapeutics (CRXT) stock

CRXT · Clarus Therapeutics Holdings Inc. · NASDAQ

Website

What is the latest news on CRXT stock?

SECago
SEC Form 15-12G filed by Clarus Therapeutics Holdings Inc.

15-12G - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

All CRXT news

When does Clarus Therapeutics report earnings?

Clarus Therapeutics last reported on May 16, 2022, the date it announced on May 12, 2022. Before that it reported on Mar 30, 2022 and Nov 18, 2021.

CRXT earnings history

Latest news

25 items

Clarus Therapeutics Holdings Inc. (CRXT) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for CRXT in the last 30 days. The most recent was published Mar 1, 2023.

Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.

CRXT FAQ

7 questions
  • What does Clarus Therapeutics Holdings Inc. do?
    Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.
  • Where does CRXT stock trade?
    Clarus Therapeutics Holdings Inc. (CRXT) is listed on NASDAQ.
  • What sector and industry is CRXT in?
    Clarus Therapeutics Holdings Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Clarus Therapeutics Holdings Inc. go public?
    Clarus Therapeutics Holdings Inc. (CRXT) completed its IPO in 2021.
  • What are analysts saying about CRXT?
    Clarus Therapeutics Holdings Inc. has had 3 recent analyst actions on file. The most recent action was from Truist Securities: Buy with a $10.00 price target on 2021-10-13. Recent price targets range from $10.00 to $13.00.
  • What companies are similar to CRXT?
    Notable peers in the same industry include JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), ABT (Abbott Laboratories), LLY (Eli Lilly and Company), NVO (Novo Nordisk A/S). Compare CRXT side-by-side with any of them on Quantisnow.
  • How can I track CRXT on Quantisnow?
    Quantisnow aggregates Clarus Therapeutics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CRXT to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change